Results 41 to 50 of about 767 (176)

Hypoxia inducible factor 3‐alpha promotes a malignant phenotype in colorectal cancer cells

open access: yesIUBMB Life, Volume 77, Issue 2, February 2025.
Abstract Colorectal cancer (CRC) is the third most common cancer worldwide. Hypoxia is a hallmark of the tumor microenvironment, and cellular adaptation to it is primarily mediated by the family of Hypoxia‐inducible factors (HIFs) HIF‐1α, HIF‐2α, and HIF‐3α. However, in contrast to HIF‐1α and HIF‐2α, a specific role for HIF‐3α in cancer biology has not
Alejandro Lopez‐Mejia   +7 more
wiley   +1 more source

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

open access: yesAnales de Pediatría (English Edition), 2018
Background and objectives: Adalimumab (ADA), a monoclonal humanised anti-TNF antibody, is usually prescribed as a second-line treatment in paediatric Crohn's disease (CD) patients who have become unresponsive or developed intolerance to infliximab (IFX).
Víctor Manuel Navas-López   +7 more
doaj   +1 more source

Linfoma colorrectal primario en paciente con colitis ulcerosa en tratamiento con anti-factor de necrosis tumoral e infección por citomegalovirus

open access: yesEndoscopia, 2021
El uso prolongado de terapia anti-factor de necrosis tumoral es cada vez más frecuente en los pacientes con enfermedad inflamatoria intestinal.
J. Alberto Romero-Lozanía   +5 more
doaj   +1 more source

Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe

open access: yesPharmacoepidemiology and Drug Safety, Volume 33, Issue 8, August 2024.
ABSTRACT Purpose Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency–funded project (EUPAS39322), defined a set of metadata to describe real‐world data sources (RWDSs) and piloted metadata collection in a prototype catalogue to assist investigators from data source discoverability ...
Romin Pajouheshnia   +46 more
wiley   +1 more source

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn

open access: yesAnales de Pediatría, 2018
Resumen: Introducción y objetivos: Adalimumab (ADA), anticuerpo anti-TNF-α monoclonal recombinante de origen humano, generalmente se emplea como tratamiento de segunda línea en niños con enfermedad de Crohn (EC) que no han respondido o han perdido ...
Víctor Manuel Navas-López   +7 more
doaj   +1 more source

Anemia y enfermedad inflamatoria intestinal [PDF]

open access: yesRevista Española de Enfermedades Digestivas, 2008
La anemia es una de las complicaciones más comunes de la enfermedad inflamatoria intestinal. La alta frecuencia de valores bajos de hemoglobina en estos enfermos provoca en muchas ocasiones una infravaloración por parte del médico de esta circunstancia, lo que se traduce en la falta de un tratamiento eficaz.
Morena, F. de la, Gisbert, J. P.
openaire   +3 more sources

Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part)

open access: yesRevista de Gastroenterología de México (English Edition), 2017
This is the first Latin American Consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) regarding special situations in patients with inflammatory bowel disease (IBD).
J.K. Yamamoto-Furusho   +15 more
doaj   +1 more source

Tiempo hasta el diagnóstico en la enfermedad inflamatoria intestinal pediátrica: claves para un diagnóstico precoz

open access: yesAnales de Pediatría, 2020
Resumen: La enfermedad inflamatoria intestinal pediátrica continúa siendo poco prevalente en nuestro medio. El comienzo de los síntomas puede ser insidioso y el diagnóstico precoz permite disminuir las complicaciones y las secuelas de la enfermedad, así ...
Javier Martín-de-Carpi   +4 more
doaj   +1 more source

Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis

open access: yesAnales de Pediatría (English Edition), 2020
Paediatric inflammatory bowel disease is not very common in Spain. Its onset can be silent and an early diagnosis reduces complications and sequelae related to the disease, and can improve the prognosis.
Javier Martín-de-Carpi   +4 more
doaj   +1 more source

Ueg Week 2020 Poster Presentations

open access: yes, 2020
United European Gastroenterology Journal, Volume 8, Issue S8, Page 144-887, October 2020.
wiley   +1 more source

Home - About - Disclaimer - Privacy